U-Blot® Research Grade Anti-Human CD25/IL2RA (RO7296682)Cat. No. WA1468Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD25/IL2RA (RO7296682)Cat. No. WA1468
U-Blot® Research Grade Anti-Human CD25/IL2RA (RA8)Cat. No. WA1467
U-Blot® Research Grade Anti-Human CD25/IL2RA (CYT-91000)Cat. No. WA1466
U-Blot® Research Grade Anti-Human CD246/ALK (DLX521)Cat. No. WA1465
U-Blot® Research Grade Anti-Human CD246/ALK (CDX-0125-TEI)Cat. No. WA1464
U-Blot® Research Grade Anti-Human CD240D/RHD Antibody (LFB Anti-RhD)Cat. No. WA1463
U-Blot® Research Grade Anti-Human CD24 (ATG 031)Cat. No. WA1462
U-Blot® Research Grade Anti-Human CD228/MELTF Antibody (SC-005)Cat. No. WA1461
U-Blot® Research Grade Anti-Human CD228/MELTF Antibody (hL49HALC)Cat. No. WA1460
U-Blot® Research Grade Anti-Human CD227/MUC1 antibody (CMB-401)Cat. No. WA1459
U-Blot® Research Grade Anti-Human CD227/MUC1 (TF10)Cat. No. WA1458
U-Blot® Research Grade Anti-Human CD227/MUC1 (TAB-004)Cat. No. WA1457